What is the definition of Metastatic Insulinoma?

Metastatic insulinoma is a very rare type of neuroendocrine cancer that occurs as a tumor in the pancreas and produces extra insulin (hyperinsulinemia), causing low blood sugar levels (hypoglycemia). Metastatic insulinoma can spread to the lymph nodes and liver.

What are the symptoms for Metastatic Insulinoma?

Symptoms of malignant insulinoma may include weakness; tremor; palpitations; rapid heartbeat; excessive sweating; increased appetite; vision, behavioral, and personality changes; seizures; coma; and death.

What are the current treatments for Metastatic Insulinoma?

Treatment for malignant insulinoma may include wide resection surgery of the pancreas and liver, somatostatin analogues (octreotide) and mTOR inhibitors to control blood glucose levels, chemoembolization, radiofrequency ablation (RFA), and kinase inhibitors (sunitinib malate).
  • Condition: Intractable Hypoglycemia in Metastatic Insulinoma
  • Journal: Pancreas
  • Treatment Used: Liver-Directed Therapy
  • Number of Patients: 7
  • Published —
The study researched the safety and effectiveness of liver-directed therapy in patients with intractable hypoglycemia in metastatic insulinoma.
  • Condition: Hormonal Syndromes in Pancreatic Neuroendocrine Tumors
  • Journal: Hepatic oncology
  • Treatment Used: Selective Internal Radiation Therapy
  • Number of Patients: 2
  • Published —
The study researched the safety and effectiveness of selective internal radiation therapy for patients with hormonal syndromes in pancreatic neuroendocrine tumors.

There are no recent clinical trials available for this condition. Please check back because new trials are being conducted frequently.